Understanding SARS-CoV-2-Mediated Inflammatory Responses: From

Currently there is no effective antiviral therapy for SARS-CoV-2 infection, which frequently leads to fatal inflammatory responses and acute lung injury. Here, we discuss the various mechanisms of SARS-CoV-mediated inflammation. We also assume that SARS-CoV-2 likely shares similar inflammatory responses. Potential therapeutic tools to reduce SARS-CoV-2-induced inflammatory responses include various methods to block FcR activation. In the absence of a proven clinical FcR blocker, the use of intravenous immunoglobulin to block FcR activation may be a viable option for the urgent treatment of pulmonary inflammation to prevent severe lung injury. Such treatment may also be combined with systemic anti-inflammatory drugs or corticosteroids. However, these strategies, as proposed here, remain to be clinically tested for effectiveness.

Study reveals how young children's immune systems tame SARS-CoV-2

Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome

The changing landscape of COVID-19 testing – the potential of T-cell response monitoring

Why does COVID-19 disproportionately affect older people?

Mechanisms of SARS-CoV-2 Transmission and Pathogenesis: Trends in Immunology

The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy, Journal of Biomedical Science

Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools

New research supports finding explaining why some patients may test positive for COVID-19 long after recovery

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Pulmonary surfactant-mediated inflammatory response against SARS-CoV-2

COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies

Guide to Understanding Th1 and Th2 Cells - Assay Genie

Single‐cell analyses reveal SARS‐CoV‐2 interference with intrinsic immune response in the human gut

Human Galectin-9 Potently Enhances SARS-CoV-2 Replication and Inflammation In Airway Epithelial Cells

Testing Host Immune Responses and Transmissibility